|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-7-9
|
|
pubmed:abstractText |
Hemorrhage is the major complication of IV recombinant tissue plasminogen activator (rt-PA) treatment for stroke. We report three patients with mild or indistinct cardiac symptoms prior to thrombolysis in whom hemodynamically significant cardiac tamponade occurred after treatment with rt-PA. Acute ischemic stroke patients may have undetected myocardial or pericardial disease that may pose a risk for hemopericardium and life-threatening tamponade after treatment with rt-PA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1857-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9633741-Aged,
pubmed-meshheading:9633741-Brain Ischemia,
pubmed-meshheading:9633741-Cardiac Tamponade,
pubmed-meshheading:9633741-Cerebrovascular Disorders,
pubmed-meshheading:9633741-Fatal Outcome,
pubmed-meshheading:9633741-Female,
pubmed-meshheading:9633741-Humans,
pubmed-meshheading:9633741-Middle Aged,
pubmed-meshheading:9633741-Pericardial Effusion,
pubmed-meshheading:9633741-Plasminogen Activators,
pubmed-meshheading:9633741-Recombinant Proteins,
pubmed-meshheading:9633741-Thrombolytic Therapy,
pubmed-meshheading:9633741-Tissue Plasminogen Activator
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke.
|
|
pubmed:affiliation |
University of Pennsylvania Medical Center, Philadelphia, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
